Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in DCIS
Oct 23, 2023•20 min
Episode description
Interview with Seema A. Khan, MD, author of Presurgical Oral Tamoxifen vs Transdermal 4-Hydroxytamoxifen in Women With Ductal Carcinoma In Situ: A Randomized Clinical Trial. Hosted by Amalia Cochran, MD.
Related Content:
For the best experience, listen in Metacast app for iOS or Android
